|
Dan Leonard specializes in research and investment in life sciences tools and diagnostics and other selected areas of the chemistry-enabled sector. He provides research coverage of leading private and publicly traded companies in his segments. Prior to joining First Analysis in 2002, he was an analyst in the life sciences division of Simon-Kucher & Partners, where he specialized in pricing strategy for pharmaceuticals. He earned an MBA from the University of Chicago and a bachelor’s degree in economics from the University of Michigan. | 